APF530
C2006-01
Phase 3 small_molecule completed
Quick answer
APF530 for Nausea and Vomiting is a Phase 3 program (small_molecule) at Heron Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Heron Therapeutics
- Indication
- Nausea and Vomiting
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed